BLEOMYCIN

BLEOMYCIN was reported 10369 times

BLEOMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXTRAGONADAL PRIMARY GERM CELL TUMOUR MIXED 4 0.8000
1 PERITONEAL GLIOMATOSIS 4 0.6667
2 ABNORMAL DNA METHYLATION 5 0.6250
3 GROWING TERATOMA SYNDROME 15 0.4545
4 INFUSION SITE JOINT MOVEMENT IMPAIRMENT 4 0.4000
5 OVARIAN GERM CELL TERATOMA 32 0.4000
6 BASAL GANGLION DEGENERATION 34 0.3617
7 NECROTISING GASTRITIS 11 0.3438
8 FLAGELLATE DERMATITIS 21 0.3231
9 TERATOMA BENIGN 13 0.2407
10 TERATOMA 44 0.2047
11 TAENIASIS 6 0.1429
12 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT 6 0.1304
13 PNEUMONIA SALMONELLA 6 0.1277
14 PLEUROPARENCHYMAL FIBROELASTOSIS 13 0.1250
15 MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND 7 0.1186
16 TISSUE INFILTRATION 35 0.1186
17 CONGENITAL HEPATOBILIARY ANOMALY 4 0.1176
18 VASCULAR ACCESS SITE OCCLUSION 9 0.1139
19 ASTHENOSPERMIA 7 0.1077
20 SYNOVIAL SARCOMA 10 0.1053
21 MENINGOENCEPHALITIS AMOEBIC 6 0.1034
22 AZOOSPERMIA 39 0.1016
23 PRIMARY IMMUNODEFICIENCY SYNDROME 8 0.0988
24 CHORIOCARCINOMA 7 0.0886
25 ENDOCARDITIS NONINFECTIVE 13 0.0872
26 PENILE VEIN THROMBOSIS 4 0.0833
27 LEUKOPENIA NEONATAL 5 0.0758
28 MALIGNANT SWEAT GLAND NEOPLASM 4 0.0741
29 TULARAEMIA 7 0.0722
30 ANAESTHESIA 26 0.0712
31 CARDIAC VALVE THICKENING 4 0.0678
32 NEUTROPENIC INFECTION 61 0.0637
33 TESTICULAR CANCER METASTATIC 5 0.0581
34 COMBINED IMMUNODEFICIENCY 9 0.0559
35 AUTOIMMUNE PANCYTOPENIA 5 0.0549
36 CUTANEOUS CALCIFICATION 10 0.0546
37 NAIL BED INFLAMMATION 17 0.0533
38 CHLOROMA 22 0.0521
39 ASPLENIA 5 0.0505
40 TREATMENT RELATED SECONDARY MALIGNANCY 10 0.0493
41 UTERINE ENLARGEMENT 35 0.0441
42 INFUSION SITE ULCER 4 0.0435
43 INFUSION SITE HYPOAESTHESIA 4 0.0421
44 OROPHARYNGEAL SQUAMOUS CELL CARCINOMA 6 0.0417
45 TOOTH MALFORMATION 7 0.0405
46 ACUTE MYELOMONOCYTIC LEUKAEMIA 10 0.0397
47 OLIGOSPERMIA 4 0.0388
48 AUTOIMMUNE NEUTROPENIA 11 0.0381
49 HIGH-GRADE B-CELL LYMPHOMA 7 0.0374
50 ACANTHAMOEBA INFECTION 7 0.0372
51 ABDOMINAL COMPARTMENT SYNDROME 23 0.0361
52 OOPHORITIS 5 0.0352
53 PULMONARY TOXICITY 247 0.0349
54 PSYCHOGENIC SEIZURE 31 0.0332
55 BRACHIOCEPHALIC VEIN THROMBOSIS 4 0.0325
56 DIAPHRAGM MUSCLE WEAKNESS 5 0.0316
57 HYPOCHROMIC ANAEMIA 32 0.0316
58 VOCAL CORD INFLAMMATION 9 0.0305
59 LIPOMATOSIS 6 0.0303
60 MALIGNANT FIBROUS HISTIOCYTOMA 4 0.0296
61 NASAL MUCOSAL DISORDER 17 0.0292
62 SEPTIC ENCEPHALOPATHY 5 0.0291
63 GERM CELL CANCER 4 0.0276
64 MENINGITIS STREPTOCOCCAL 4 0.0274
65 PREMATURE AGEING 8 0.0272
66 ACUTE PROMYELOCYTIC LEUKAEMIA 27 0.0263
67 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 6 0.0261
68 COLITIS EROSIVE 4 0.0252
69 NAIL PIGMENTATION 6 0.0248
70 CARBON MONOXIDE DIFFUSING CAPACITY DECREASED 4 0.0235
71 OSTEOSARCOMA 9 0.0234
72 REFRACTORY CANCER 5 0.0234
73 BLOOD STEM CELL TRANSPLANT FAILURE 5 0.0233
74 LISTERIA SEPSIS 6 0.0227
75 MALIGNANT TRANSFORMATION 10 0.0223
76 LYMPHOMA TRANSFORMATION 8 0.0222
77 HODGKIN'S DISEASE 16 0.0221
78 VULVOVAGINAL INFLAMMATION 10 0.0217
79 BIFASCICULAR BLOCK 4 0.0214
80 INFUSION SITE NECROSIS 4 0.0208
81 PNEUMOMEDIASTINUM 37 0.0205
82 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 12 0.0202
83 EPIPHYSIOLYSIS 5 0.0201
84 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 6 0.0192
85 PATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0187
86 CEREBRAL ARTERY STENOSIS 9 0.0184
87 B PRECURSOR TYPE ACUTE LEUKAEMIA 7 0.0180
88 RENAL SALT-WASTING SYNDROME 7 0.0179
89 SUBCUTANEOUS EMPHYSEMA 17 0.0173
90 PNEUMONITIS CHEMICAL 6 0.0172
91 TRAUMATIC LUNG INJURY 33 0.0171
92 OESOPHAGEAL PERFORATION 14 0.0168
93 SECOND PRIMARY MALIGNANCY 139 0.0167
94 BONE MARROW TOXICITY 19 0.0160
95 STREPTOCOCCAL SEPSIS 19 0.0160
96 HERPES SIMPLEX REACTIVATION 6 0.0157
97 GASTROENTERITIS BACTERIAL 5 0.0152
98 TESTICULAR DISORDER 15 0.0149
99 DILATED CARDIOMYOPATHY 15 0.0148
100 SPERM CONCENTRATION DECREASED 5 0.0145
101 VASOGENIC CEREBRAL OEDEMA 10 0.0139
102 CEREBRAL ARTERY THROMBOSIS 7 0.0136
103 NEONATAL HYPOTENSION 5 0.0136
104 NEUROLOGICAL DECOMPENSATION 31 0.0134
105 CYTOMEGALOVIRUS CHORIORETINITIS 26 0.0133
106 LUNG INJURY 4 0.0132
107 VENA CAVA THROMBOSIS 22 0.0132
108 PATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0132
109 CATARACT SUBCAPSULAR 8 0.0131
110 MEDIASTINAL MASS 5 0.0131
111 ISCHAEMIC CEREBRAL INFARCTION 15 0.0129
112 MYELITIS 20 0.0129
113 PERIPHERAL NERVE INJURY 11 0.0125
114 ACUTE MYELOID LEUKAEMIA 195 0.0125
115 ANAEMIA NEONATAL 6 0.0124
116 RETROPERITONEAL FIBROSIS 7 0.0120
117 PERICARDITIS CONSTRICTIVE 5 0.0118
118 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 7 0.0118
119 CAROTID ARTERY THROMBOSIS 10 0.0118
120 CAROTID ARTERY DISSECTION 5 0.0117
121 INVASIVE LOBULAR BREAST CARCINOMA 6 0.0117
122 PAPILLARY THYROID CANCER 20 0.0115
123 PEPTIC ULCER HAEMORRHAGE 8 0.0115
124 DYSAESTHESIA 34 0.0111
125 B-CELL LYMPHOMA RECURRENT 6 0.0110
126 CEREBRAL MASS EFFECT 4 0.0110
127 ACUTE LUNG INJURY 13 0.0110
128 PREMATURE MENOPAUSE 10 0.0108
129 PRETERM PREMATURE RUPTURE OF MEMBRANES 13 0.0108
130 KLEBSIELLA INFECTION 54 0.0107
131 PATERNAL DRUGS AFFECTING FOETUS 4 0.0107
132 KLEBSIELLA SEPSIS 12 0.0106
133 HAEMATOTOXICITY 101 0.0106
134 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 23 0.0104
135 PSEUDOMONAL SEPSIS 18 0.0103
136 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 4 0.0102
137 PERIPHERAL SENSORY NEUROPATHY 59 0.0101
138 SUPERIOR SAGITTAL SINUS THROMBOSIS 8 0.0100
139 EMBOLISM ARTERIAL 12 0.0100
140 DEMYELINATING POLYNEUROPATHY 10 0.0097
141 NEUTROPENIC COLITIS 20 0.0097
142 CARDIOTOXICITY 86 0.0096
143 GLOMERULOSCLEROSIS 6 0.0095
144 ADRENAL SUPPRESSION 8 0.0095
145 RETROPERITONEAL LYMPHADENOPATHY 5 0.0095
146 HEPATITIS B REACTIVATION 30 0.0094
147 CEREBRAL ARTERY OCCLUSION 10 0.0093
148 OTOTOXICITY 17 0.0092
149 INFUSION SITE SCAR 4 0.0090
150 PARAPARESIS 16 0.0090
151 VANISHING BILE DUCT SYNDROME 10 0.0090
152 MYELODYSPLASTIC SYNDROME 128 0.0088
153 CEREBRAL MICROHAEMORRHAGE 4 0.0088
154 COMPUTERISED TOMOGRAM THORAX ABNORMAL 6 0.0087
155 HYPERBILIRUBINAEMIA NEONATAL 5 0.0086
156 PERIPHERAL ARTERY THROMBOSIS 12 0.0085
157 HYPERPYREXIA 36 0.0085
158 PULMONARY VASCULAR DISORDER 4 0.0085
159 THALAMIC INFARCTION 5 0.0084
160 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 11 0.0084
161 CEREBRAL VENOUS THROMBOSIS 15 0.0083
162 FEBRILE NEUTROPENIA 547 0.0082
163 FEBRILE BONE MARROW APLASIA 35 0.0082
164 MYELOID LEUKAEMIA 4 0.0080
165 LYMPHOCYTIC INFILTRATION 8 0.0079
166 NEONATAL RESPIRATORY FAILURE 4 0.0079
167 PERIPHERAL MOTOR NEUROPATHY 11 0.0078
168 LEFT VENTRICULAR DILATATION 4 0.0078
169 NEUTROPENIC SEPSIS 54 0.0076
170 PNEUMOCYSTIS JIROVECII INFECTION 9 0.0075
171 INTERVERTEBRAL DISC DISORDER 32 0.0075
172 ACUTE LEUKAEMIA 12 0.0074
173 MEASLES 4 0.0074
174 PARANEOPLASTIC SYNDROME 5 0.0074
175 SARCOIDOSIS 35 0.0074
176 MONOPLEGIA 32 0.0074
177 PULMONARY FIBROSIS 140 0.0073
178 PNEUMOCYSTIS JIROVECI PNEUMONIA 16 0.0072
179 PERIPHERAL SENSORIMOTOR NEUROPATHY 9 0.0072
180 APLASIA 14 0.0071
181 ALPHA 1 FOETOPROTEIN INCREASED 5 0.0070
182 CORONARY ARTERY THROMBOSIS 14 0.0069
183 SUBDURAL HAEMORRHAGE 19 0.0069
184 COMA HEPATIC 5 0.0067
185 HISTIOCYTOSIS HAEMATOPHAGIC 20 0.0067
186 ACUTE LYMPHOCYTIC LEUKAEMIA 19 0.0067
187 LYMPHATIC DISORDER 4 0.0067
188 RECTAL ADENOCARCINOMA 4 0.0066
189 DISSEMINATED CRYPTOCOCCOSIS 5 0.0066
190 ABDOMINAL TENDERNESS 32 0.0064
191 HEPATOBILIARY DISEASE 4 0.0064
192 ESCHERICHIA BACTERAEMIA 15 0.0064
193 PNEUMOCYSTIS JIROVECII PNEUMONIA 64 0.0064
194 MYCOBACTERIUM AVIUM COMPLEX INFECTION 17 0.0063
195 QUADRIPLEGIA 13 0.0063
196 CHRONIC MYELOID LEUKAEMIA 29 0.0063
197 NODULAR REGENERATIVE HYPERPLASIA 4 0.0062
198 ARTERIAL THROMBOSIS 12 0.0062
199 SUBCLAVIAN VEIN THROMBOSIS 7 0.0061
200 VOCAL CORD PARALYSIS 11 0.0061
201 C-REACTIVE PROTEIN DECREASED 4 0.0061
202 NON-HODGKIN'S LYMPHOMA 8 0.0061
203 PAPILLOMA VIRAL INFECTION 10 0.0061
204 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 4 0.0060
205 MUCOSAL INFLAMMATION 156 0.0060
206 CORONARY ARTERY DISSECTION 5 0.0058
207 ANGULAR CHEILITIS 4 0.0058
208 INGUINAL HERNIA 35 0.0057
209 ENCEPHALITIS VIRAL 7 0.0057
210 SPLENIC INFARCTION 10 0.0057
211 INTESTINAL PSEUDO-OBSTRUCTION 5 0.0057
212 ACUTE RESPIRATORY DISTRESS SYNDROME 100 0.0056
213 VENOOCCLUSIVE DISEASE 14 0.0056
214 PNEUMONITIS 151 0.0055
215 STREPTOCOCCAL BACTERAEMIA 6 0.0055
216 VENOOCCLUSIVE LIVER DISEASE 27 0.0055
217 MICROCEPHALY 7 0.0055
218 CARDIAC DYSFUNCTION 20 0.0054
219 HYPERVENTILATION 31 0.0053
220 ACQUIRED GENE MUTATION 7 0.0053
221 T-CELL LYMPHOMA 6 0.0052
222 TUMOUR LYSIS SYNDROME 46 0.0052
223 DIFFUSE ALVEOLAR DAMAGE 6 0.0052
224 AORTIC THROMBOSIS 6 0.0052
225 BONE MARROW DEPRESSION 5 0.0051
226 RESTRICTIVE PULMONARY DISEASE 6 0.0051
227 SINUS ARREST 8 0.0051
228 OLIGOHYDRAMNIOS 17 0.0051
229 AORTIC VALVE DISEASE 8 0.0050
230 SECONDARY IMMUNODEFICIENCY 6 0.0049
231 FOETAL GROWTH RESTRICTION 30 0.0049
232 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 4 0.0049
233 AREFLEXIA 13 0.0049
234 CAPILLARY LEAK SYNDROME 10 0.0048
235 CONGESTIVE CARDIOMYOPATHY 20 0.0048
236 INFUSION SITE OEDEMA 4 0.0048
237 SYSTEMIC CANDIDA 12 0.0048
238 LEFT VENTRICULAR DYSFUNCTION 32 0.0048
239 BLOOD BILIRUBIN ABNORMAL 6 0.0047
240 HEPATIC HAEMORRHAGE 4 0.0047
241 RENAL CYST 37 0.0047
242 LUNG INFILTRATION 41 0.0046
243 EXPOSURE VIA FATHER 6 0.0046
244 MENINGITIS CRYPTOCOCCAL 8 0.0046
245 RESPIRATORY SYMPTOM 13 0.0046
246 MITRAL VALVE DISEASE 8 0.0045
247 LARYNGEAL CANCER 5 0.0045
248 CANDIDA SEPSIS 4 0.0045
249 NEUROPSYCHIATRIC SYMPTOMS 4 0.0044
250 HUMAN CHORIONIC GONADOTROPIN INCREASED 4 0.0044
251 STEM CELL TRANSPLANT 11 0.0044
252 CANDIDA INFECTION 74 0.0044
253 BONE MARROW FAILURE 89 0.0044
254 THERAPY PARTIAL RESPONDER 68 0.0044
255 GUILLAIN-BARRE SYNDROME 21 0.0043
256 CRYPTOCOCCOSIS 7 0.0043
257 PELVIC VENOUS THROMBOSIS 6 0.0042
258 METASTASES TO LYMPH NODES 28 0.0041
259 NEOPLASM RECURRENCE 14 0.0041
260 CLOSTRIDIUM COLITIS 5 0.0041
261 PHARYNGEAL INFLAMMATION 5 0.0041
262 PARONYCHIA 18 0.0041
263 AUTOIMMUNE HAEMOLYTIC ANAEMIA 14 0.0041
264 HAEMOPHILUS INFECTION 4 0.0041
265 ORGANISING PNEUMONIA 20 0.0040
266 EMPYEMA 8 0.0040
267 PRINZMETAL ANGINA 4 0.0040
268 RENAL ATROPHY 5 0.0040
269 VASCULAR DEVICE INFECTION 18 0.0040
270 AUTONOMIC NEUROPATHY 4 0.0039
271 NEUTROPHIL COUNT ABNORMAL 11 0.0039
272 METASTASES TO SKIN 4 0.0039
273 PNEUMOTHORAX 60 0.0038
274 GRANULOMA 13 0.0038
275 POSTPARTUM HAEMORRHAGE 5 0.0037
276 EPSTEIN-BARR VIRUS INFECTION 23 0.0037
277 OSTEOPOROTIC FRACTURE 7 0.0037
278 SPLENIC RUPTURE 6 0.0036
279 BRAIN OEDEMA 46 0.0036
280 BONE MARROW DISORDER 11 0.0036
281 LISTERIOSIS 4 0.0036
282 VIRAEMIA 5 0.0036
283 PNEUMONIA CYTOMEGALOVIRAL 7 0.0036
284 FIBROSIS 11 0.0036
285 LYMPHOCYTE COUNT ABNORMAL 4 0.0036
286 CYTOGENETIC ABNORMALITY 4 0.0035
287 ALVEOLITIS 5 0.0035
288 IMMUNE THROMBOCYTOPENIC PURPURA 10 0.0035
289 INFECTION REACTIVATION 4 0.0035
290 EXTREMITY NECROSIS 6 0.0034
291 PULMONARY SEPSIS 5 0.0034
292 SPLENOMEGALY 40 0.0034
293 LYMPHOPROLIFERATIVE DISORDER 10 0.0034
294 LEUKAEMIA 32 0.0034
295 ATRIAL THROMBOSIS 7 0.0034
296 VARICELLA ZOSTER VIRUS INFECTION 7 0.0034
297 METASTASIS 24 0.0034
298 RESPIRATORY FAILURE 243 0.0033
299 LUNG ADENOCARCINOMA 10 0.0033
300 INFERTILITY 5 0.0033
301 NEUTROPENIA 449 0.0033
302 DIFFUSE LARGE B-CELL LYMPHOMA 25 0.0032
303 STENOSIS 6 0.0032
304 PLATELET DISORDER 8 0.0032
305 HEPATITIS E 5 0.0032
306 LEFT ATRIAL DILATATION 4 0.0031
307 INTERSTITIAL LUNG DISEASE 151 0.0031
308 VENTRICULAR HYPOKINESIA 10 0.0031
309 VARICOSE VEIN 16 0.0031
310 ACUTE HEPATIC FAILURE 42 0.0031
311 RED BLOOD CELL SEDIMENTATION RATE INCREASED 34 0.0031
312 BACTERIAL SEPSIS 10 0.0031
313 APLASTIC ANAEMIA 16 0.0031
314 OBLITERATIVE BRONCHIOLITIS 4 0.0030
315 PULMONARY CONGESTION 39 0.0030
316 MULTIPLE-DRUG RESISTANCE 9 0.0029
317 SPINAL PAIN 34 0.0029
318 DILATATION VENTRICULAR 6 0.0029
319 H1N1 INFLUENZA 4 0.0028
320 PERIPHERAL ARTERY OCCLUSION 4 0.0028
321 BLOOD LACTIC ACID INCREASED 15 0.0028
322 DEAFNESS 74 0.0028
323 PREMATURE LABOUR 16 0.0028
324 HEART DISEASE CONGENITAL 10 0.0028
325 HEPATITIS B 17 0.0028
326 ILEAL STENOSIS 5 0.0028
327 CUSHINGOID 9 0.0028
328 CYTOPENIA 34 0.0028
329 MUSCLE SPASTICITY 34 0.0028
330 NORMOCYTIC ANAEMIA 4 0.0027
331 RECURRENT CANCER 11 0.0027
332 SEPTIC SHOCK 117 0.0027
333 PANCYTOPENIA 150 0.0027
334 MENINGITIS ASEPTIC 12 0.0027
335 LUNG OPACITY 7 0.0027
336 CARDIOMYOPATHY 39 0.0026
337 BACTERIAL INFECTION 49 0.0026
338 LYMPHADENOPATHY MEDIASTINAL 5 0.0026
339 NEURITIS 4 0.0026
340 NEPHROPATHY TOXIC 29 0.0026
341 THROMBOTIC MICROANGIOPATHY 25 0.0026
342 THROMBOCYTOPENIA 285 0.0025
343 LYMPHOPENIA 36 0.0025
344 NEONATAL RESPIRATORY DISTRESS SYNDROME 9 0.0025
345 FUNGAEMIA 4 0.0025
346 OPHTHALMOPLEGIA 4 0.0025
347 EMBOLISM 21 0.0025
348 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 24 0.0025
349 LUNG CONSOLIDATION 7 0.0025
350 JC VIRUS INFECTION 4 0.0025
351 TENDERNESS 26 0.0025
352 PREMATURE BABY 75 0.0025
353 PREMATURE RUPTURE OF MEMBRANES 6 0.0025
354 RENAL TUBULAR DISORDER 7 0.0025
355 DEVICE RELATED SEPSIS 5 0.0025
356 HYPOKINESIA 36 0.0025
357 ACUTE MYOCARDIAL INFARCTION 73 0.0025
358 CYTOMEGALOVIRUS INFECTION 41 0.0025
359 NEUROTOXICITY 43 0.0025
360 PULMONARY HAEMORRHAGE 19 0.0024
361 METASTASES TO CENTRAL NERVOUS SYSTEM 31 0.0024
362 LUNG ABSCESS 5 0.0024
363 HEPATORENAL SYNDROME 4 0.0024
364 LYMPHADENOPATHY 83 0.0023
365 LEUKOPENIA 117 0.0023
366 DISEASE RECURRENCE 111 0.0023
367 DISEASE PROGRESSION 276 0.0023
368 LYMPHOCYTOSIS 5 0.0023
369 BRONCHOPULMONARY ASPERGILLOSIS 18 0.0023
370 CHRONIC LYMPHOCYTIC LEUKAEMIA 11 0.0023
371 EJECTION FRACTION DECREASED 36 0.0023
372 HYPERAMMONAEMIC ENCEPHALOPATHY 4 0.0023
373 CERVICAL DYSPLASIA 5 0.0023
374 PULMONARY FUNCTION TEST DECREASED 10 0.0023
375 GRANULOCYTOPENIA 13 0.0023
376 LOW BIRTH WEIGHT BABY 18 0.0023
377 OBESITY 36 0.0023
378 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
379 LUNG DISORDER 109 0.0022
380 SMALL FOR DATES BABY 11 0.0022
381 SCLERODERMA 8 0.0022
382 OSTEONECROSIS 71 0.0022
383 DIFFUSE ALOPECIA 4 0.0022
384 BILIRUBIN CONJUGATED INCREASED 5 0.0021
385 ASPERGILLUS INFECTION 14 0.0021
386 JAUNDICE NEONATAL 4 0.0021
387 PNEUMATOSIS INTESTINALIS 6 0.0021
388 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
389 HYPOVOLAEMIC SHOCK 10 0.0021
390 PARAPLEGIA 6 0.0021
391 HEPATIC MASS 4 0.0021
392 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
393 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
394 DRUG RESISTANCE 53 0.0021
395 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 17 0.0021
396 B-CELL LYMPHOMA 7 0.0021
397 TESTIS CANCER 8 0.0020
398 HEPATITIS FULMINANT 6 0.0020
399 SEPSIS 225 0.0020
400 POLYNEUROPATHY 24 0.0020
401 HYDRONEPHROSIS 15 0.0020
402 METASTASES TO PERITONEUM 5 0.0020
403 IMMUNE THROMBOCYTOPENIA 9 0.0020
404 HYPERURICAEMIA 8 0.0019
405 SKIN TOXICITY 11 0.0019
406 HEPATIC STEATOSIS 36 0.0019
407 ACUTE CORONARY SYNDROME 16 0.0019
408 HYPOXIA 68 0.0019
409 HEPATIC ENCEPHALOPATHY 18 0.0019
410 EOSINOPHILIC PNEUMONIA 6 0.0019
411 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
412 WHITE BLOOD CELL COUNT ABNORMAL 12 0.0019
413 AORTIC VALVE INCOMPETENCE 8 0.0019
414 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
415 CARDIAC FAILURE CHRONIC 8 0.0019
416 RADIATION PNEUMONITIS 4 0.0019
417 HAEMOGLOBIN ABNORMAL 12 0.0019
418 ACUTE MYELOID LEUKAEMIA RECURRENT 4 0.0019
419 ISCHAEMIC STROKE 33 0.0018
420 METASTASES TO LUNG 21 0.0018
421 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9 0.0018
422 VENOUS THROMBOSIS 7 0.0018
423 SLEEP APNOEA SYNDROME 34 0.0018
424 WOUND DEHISCENCE 6 0.0018
425 MYELOSUPPRESSION 63 0.0017
426 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 13 0.0017
427 HAEMOLYTIC URAEMIC SYNDROME 4 0.0017
428 ESCHERICHIA SEPSIS 5 0.0017
429 HEPATOTOXICITY 38 0.0017
430 INTESTINAL PERFORATION 19 0.0017
431 HYPOTHYROIDISM 54 0.0017
432 HEMIPLEGIA 14 0.0017
433 GRAFT VERSUS HOST DISEASE 12 0.0017
434 PANNICULITIS 4 0.0017
435 BUNDLE BRANCH BLOCK LEFT 7 0.0016
436 THROMBOCYTOSIS 6 0.0016
437 CEREBRAL INFARCTION 40 0.0016
438 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
439 PREMATURE DELIVERY 26 0.0016
440 STAPHYLOCOCCAL SEPSIS 8 0.0016
441 BRAIN DEATH 5 0.0016
442 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
443 LYMPHOEDEMA 11 0.0016
444 MASS 22 0.0016
445 NOCARDIOSIS 4 0.0016
446 CATHETER SITE PAIN 4 0.0015
447 EPIGASTRIC DISCOMFORT 6 0.0015
448 RENAL TUBULAR NECROSIS 15 0.0015
449 ARTERIAL OCCLUSIVE DISEASE 12 0.0015
450 NAIL DISCOLOURATION 6 0.0015
451 NEUTROPHIL COUNT DECREASED 62 0.0015
452 DEAFNESS NEUROSENSORY 5 0.0015
453 CARDIAC FAILURE ACUTE 10 0.0015
454 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
455 ABDOMINAL MASS 4 0.0015
456 BRONCHIECTASIS 10 0.0015
457 IMMUNOSUPPRESSION 13 0.0015
458 HYDROCEPHALUS 8 0.0015
459 CARDIOGENIC SHOCK 21 0.0015
460 GASTROINTESTINAL TOXICITY 7 0.0015
461 INTESTINAL ISCHAEMIA 8 0.0015
462 LEFT VENTRICULAR FAILURE 5 0.0015
463 FOETAL EXPOSURE DURING PREGNANCY 118 0.0015
464 PLEURITIC PAIN 4 0.0014
465 ENCEPHALITIS 10 0.0014
466 HAIR GROWTH ABNORMAL 10 0.0014
467 VIRAL INFECTION 48 0.0014
468 HYPOMAGNESAEMIA 20 0.0014
469 NEUROPATHY PERIPHERAL 136 0.0014
470 PLEURAL EFFUSION 87 0.0014
471 ANGIOPATHY 8 0.0014
472 ENDOTRACHEAL INTUBATION 4 0.0014
473 FACIAL PARALYSIS 12 0.0014
474 HYPOTONIA 14 0.0014
475 AGRANULOCYTOSIS 26 0.0014
476 SKIN HYPERPIGMENTATION 12 0.0014
477 ANAEMIA 266 0.0014
478 CORONARY ARTERY STENOSIS 7 0.0014
479 COAGULOPATHY 23 0.0014
480 GASTROINTESTINAL NECROSIS 4 0.0014
481 CAROTID ARTERY OCCLUSION 5 0.0014
482 HYPOVOLAEMIA 8 0.0014
483 PULMONARY EMBOLISM 128 0.0013
484 SINUS BRADYCARDIA 13 0.0013
485 DEEP VEIN THROMBOSIS 86 0.0013
486 NEOPLASM PROGRESSION 46 0.0013
487 MALIGNANT NEOPLASM PROGRESSION 134 0.0013
488 ISCHAEMIA 6 0.0013
489 CHEST X-RAY ABNORMAL 4 0.0013
490 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
491 RESPIRATORY DISTRESS 36 0.0013
492 EXPOSURE DURING PREGNANCY 81 0.0013
493 PIGMENTATION DISORDER 8 0.0013
494 ARTHRITIS INFECTIVE 6 0.0013
495 SCOLIOSIS 8 0.0013
496 HYPOALBUMINAEMIA 10 0.0013
497 PSEUDOMONAS INFECTION 11 0.0013
498 CARDIOPULMONARY FAILURE 5 0.0013
499 RETINAL HAEMORRHAGE 9 0.0013
500 ACUTE RESPIRATORY FAILURE 24 0.0012
501 CYSTITIS HAEMORRHAGIC 5 0.0012
502 PORTAL VEIN THROMBOSIS 4 0.0012
503 HERPES SIMPLEX 8 0.0012
504 HAEMOLYTIC ANAEMIA 11 0.0012
505 HEPATIC FAILURE 37 0.0012
506 HEPATIC NEOPLASM 4 0.0012
507 NEOPLASM 14 0.0012
508 BONE PAIN 71 0.0012
509 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
510 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
511 ILEUS 15 0.0012
512 CYTOLYTIC HEPATITIS 4 0.0012
513 STRESS CARDIOMYOPATHY 7 0.0012
514 METASTASES TO SPINE 4 0.0012
515 TROPONIN INCREASED 9 0.0012
516 BACTERAEMIA 14 0.0012
517 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 6 0.0012
518 TOXICITY TO VARIOUS AGENTS 198 0.0012
519 ODYNOPHAGIA 7 0.0012
520 RESPIRATORY DISORDER 35 0.0012
521 LYMPHOMA 18 0.0012
522 METASTATIC NEOPLASM 5 0.0012
523 BLOOD CREATININE ABNORMAL 4 0.0012
524 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
525 MITRAL VALVE INCOMPETENCE 13 0.0011
526 TRANSFUSION 12 0.0011
527 PERICARDIAL EFFUSION 26 0.0011
528 STOMATITIS 68 0.0011
529 ILEUS PARALYTIC 5 0.0011
530 HAEMATOMA 29 0.0011
531 CAESAREAN SECTION 13 0.0011
532 PAPILLOEDEMA 5 0.0011
533 ASTHMATIC CRISIS 4 0.0011
534 ESCHERICHIA INFECTION 9 0.0011
535 ENTERITIS 7 0.0011
536 TOXIC SKIN ERUPTION 11 0.0011
537 C-REACTIVE PROTEIN ABNORMAL 7 0.0011
538 SUBARACHNOID HAEMORRHAGE 11 0.0011
539 NECROSIS 6 0.0011
540 ATRIAL SEPTAL DEFECT 9 0.0011
541 NEUTROPHIL COUNT INCREASED 11 0.0011
542 GASTRITIS EROSIVE 5 0.0011
543 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
544 HEMIPARESIS 18 0.0011
545 CATHETER SITE INFECTION 4 0.0011
546 CARDIAC TAMPONADE 5 0.0011
547 SUBCUTANEOUS ABSCESS 5 0.0010
548 MYOPATHY 9 0.0010
549 ENTEROCOCCAL INFECTION 5 0.0010
550 BLINDNESS 42 0.0010
551 DRUG TOXICITY 14 0.0010
552 INFECTION 148 0.0010
553 PNEUMONIA FUNGAL 4 0.0010
554 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
555 OESOPHAGITIS 11 0.0010
556 COLITIS 38 0.0010
557 BLOOD DISORDER 8 0.0010
558 CIRCULATORY COLLAPSE 17 0.0010
559 ARTERIOSPASM CORONARY 4 0.0010
560 PRODUCT USE IN UNAPPROVED INDICATION 246 0.0010
561 TACHYCARDIA 88 0.0010
562 MULTIPLE ORGAN DYSFUNCTION SYNDROME 28 0.0010
563 TOXIC ENCEPHALOPATHY 5 0.0010
564 PYREXIA 341 0.0010
565 DYSLIPIDAEMIA 5 0.0010
566 PERIPHERAL ISCHAEMIA 4 0.0010
567 ARTHRITIS BACTERIAL 4 0.0010
568 HICCUPS 8 0.0010
569 HYPERTHYROIDISM 14 0.0010
570 FOETAL DEATH 5 0.0010
571 SKIN NECROSIS 5 0.0010
572 INTESTINAL STENOSIS 4 0.0009
573 ATELECTASIS 9 0.0009
574 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 51 0.0009
575 HEPATIC LESION 4 0.0009
576 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
577 ORAL CANDIDIASIS 12 0.0009
578 DEVICE RELATED INFECTION 14 0.0009
579 ABDOMINAL ABSCESS 4 0.0009
580 ENCEPHALOPATHY 22 0.0009
581 HYPOTHERMIA 9 0.0009
582 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
583 FUNGAL INFECTION 29 0.0009
584 SKIN FISSURES 17 0.0009
585 ENTEROCOLITIS 5 0.0009
586 BLOOD URIC ACID INCREASED 5 0.0009
587 PERFORMANCE STATUS DECREASED 4 0.0009
588 DYSPHAGIA 81 0.0009
589 BLOOD BILIRUBIN INCREASED 23 0.0009
590 PRE-ECLAMPSIA 4 0.0008
591 HEPATITIS CHOLESTATIC 5 0.0008
592 DERMATITIS BULLOUS 6 0.0008
593 PLATELET COUNT ABNORMAL 5 0.0008
594 C-REACTIVE PROTEIN INCREASED 30 0.0008
595 PULMONARY HYPERTENSION 17 0.0008
596 HEPATOMEGALY 8 0.0008
597 SENSORY DISTURBANCE 13 0.0008
598 MULTI-ORGAN FAILURE 14 0.0008
599 HYPERVOLAEMIA 4 0.0008
600 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
601 PYELONEPHRITIS 7 0.0008
602 PHARYNGITIS 10 0.0008
603 OLIGURIA 5 0.0008
604 HYPOKALAEMIA 37 0.0008
605 RENAL FAILURE ACUTE 34 0.0008
606 GROIN PAIN 7 0.0008
607 GRIP STRENGTH DECREASED 7 0.0008
608 INFLAMMATION 41 0.0008
609 RESTLESSNESS 29 0.0008
610 PURPURA 7 0.0008
611 PHOTOPSIA 5 0.0008
612 BLINDNESS UNILATERAL 11 0.0008
613 LIVER INJURY 19 0.0008
614 LUNG INFECTION 12 0.0008
615 APNOEA 6 0.0008
616 DRUG-INDUCED LIVER INJURY 24 0.0008
617 TRANSAMINASES INCREASED 17 0.0008
618 CARDIAC FAILURE 61 0.0008
619 TRICUSPID VALVE INCOMPETENCE 6 0.0008
620 GINGIVITIS 4 0.0007
621 TREATMENT FAILURE 61 0.0007
622 GENERAL PHYSICAL HEALTH DETERIORATION 85 0.0007
623 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
624 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
625 OFF LABEL USE 636 0.0007
626 MATERNAL EXPOSURE DURING PREGNANCY 64 0.0007
627 RIGHT VENTRICULAR FAILURE 5 0.0007
628 HYPONATRAEMIA 40 0.0007
629 PERONEAL NERVE PALSY 4 0.0007
630 MYOCARDIAL ISCHAEMIA 8 0.0007
631 NEUROLOGICAL SYMPTOM 4 0.0007
632 CARDIAC VALVE DISEASE 4 0.0007
633 ANURIA 6 0.0007
634 METABOLIC DISORDER 4 0.0007
635 PNEUMONIA 223 0.0007
636 ASCITES 20 0.0007
637 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
638 MALIGNANT MELANOMA 9 0.0007
639 HAEMATEMESIS 17 0.0007
640 RENAL IMPAIRMENT 56 0.0007
641 SKIN DISORDER 22 0.0007
642 ANAPHYLACTIC REACTION 36 0.0007
643 GENERALISED OEDEMA 8 0.0006
644 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
645 HAIR COLOUR CHANGES 8 0.0006
646 INFUSION SITE EXTRAVASATION 4 0.0006
647 TINNITUS 29 0.0006
648 AMENORRHOEA 11 0.0006
649 HERPES ZOSTER 36 0.0006
650 MALNUTRITION 7 0.0006
651 RENAL FAILURE 83 0.0006
652 THERAPY NON-RESPONDER 28 0.0006
653 MYASTHENIA GRAVIS 5 0.0006
654 PLATELET COUNT INCREASED 8 0.0006
655 LEUKOCYTOSIS 11 0.0006
656 STAPHYLOCOCCAL INFECTION 20 0.0006
657 IMMUNODEFICIENCY 9 0.0006
658 ELECTROLYTE IMBALANCE 7 0.0006
659 LIVE BIRTH 5 0.0006
660 CHILLS 70 0.0006
661 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
662 VOMITING 280 0.0006
663 ACUTE KIDNEY INJURY 91 0.0006
664 SPEECH DISORDER 31 0.0006
665 ARRHYTHMIA 28 0.0006
666 BODY TEMPERATURE INCREASED 12 0.0006
667 ABNORMAL LOSS OF WEIGHT 4 0.0006
668 INITIAL INSOMNIA 6 0.0006
669 ECCHYMOSIS 4 0.0006
670 PLATELET COUNT DECREASED 62 0.0006
671 SLEEP DISORDER 41 0.0006
672 DRUG INTOLERANCE 56 0.0006
673 HYPERBILIRUBINAEMIA 6 0.0006
674 BASAL CELL CARCINOMA 9 0.0006
675 NO THERAPEUTIC RESPONSE 7 0.0006
676 BREAST CANCER METASTATIC 6 0.0006
677 MYOSITIS 5 0.0006
678 INTESTINAL OBSTRUCTION 21 0.0006
679 ORAL DISORDER 4 0.0005
680 MELAENA 12 0.0005
681 VENTRICULAR TACHYCARDIA 9 0.0005
682 WHITE BLOOD CELL COUNT DECREASED 59 0.0005
683 UROSEPSIS 5 0.0005
684 VENTRICULAR FIBRILLATION 6 0.0005
685 BLOOD CREATININE INCREASED 35 0.0005
686 APPENDICITIS 5 0.0005
687 PROTEINURIA 10 0.0005
688 HYPERTHERMIA 4 0.0005
689 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
690 CHOLESTASIS 10 0.0005
691 FEAR 14 0.0005
692 LIVER DISORDER 23 0.0005
693 CONGENITAL ANOMALY 4 0.0005
694 RETCHING 11 0.0005
695 NERVOUS SYSTEM DISORDER 16 0.0005
696 GASTROINTESTINAL INFLAMMATION 4 0.0005
697 CORONARY ARTERY OCCLUSION 7 0.0005
698 SKIN LESION 14 0.0005
699 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
700 STEVENS-JOHNSON SYNDROME 11 0.0005
701 ADRENAL INSUFFICIENCY 6 0.0005
702 DIALYSIS 7 0.0005
703 POST PROCEDURAL INFECTION 4 0.0005
704 RECTAL HAEMORRHAGE 21 0.0005
705 ANGINA PECTORIS 14 0.0005
706 CARDIAC ARREST 40 0.0005
707 JAUNDICE 13 0.0005
708 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
709 PERITONITIS 10 0.0005
710 COUGH 135 0.0005
711 HYPOCALCAEMIA 9 0.0005
712 INFUSION SITE ERYTHEMA 4 0.0005
713 HEPATIC CYTOLYSIS 6 0.0005
714 DRUG INTERACTION 74 0.0005
715 ORTHOSTATIC HYPOTENSION 8 0.0005
716 IMMUNE SYSTEM DISORDER 6 0.0005
717 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
718 DRUG ERUPTION 8 0.0005
719 DYSPNOEA EXERTIONAL 17 0.0005
720 NEOPLASM MALIGNANT 30 0.0004
721 ABORTION SPONTANEOUS 18 0.0004
722 THROMBOSIS 36 0.0004
723 LIVER FUNCTION TEST ABNORMAL 13 0.0004
724 SKIN INFECTION 5 0.0004
725 CYANOSIS 7 0.0004
726 TACHYPNOEA 6 0.0004
727 DRUG EFFECT INCOMPLETE 16 0.0004
728 VAGINAL HAEMORRHAGE 19 0.0004
729 NIGHT SWEATS 14 0.0004
730 GRAND MAL CONVULSION 4 0.0004
731 CONJUNCTIVITIS 8 0.0004
732 MOUTH ULCERATION 9 0.0004
733 BLOOD TEST ABNORMAL 6 0.0004
734 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
735 DYSARTHRIA 16 0.0004
736 ABORTION INDUCED 4 0.0004
737 PULMONARY OEDEMA 19 0.0004
738 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
739 SINUS TACHYCARDIA 6 0.0004
740 LOSS OF CONSCIOUSNESS 54 0.0004
741 DRUG ABUSE 35 0.0004
742 MYOCLONUS 5 0.0004
743 CEREBRAL HAEMORRHAGE 15 0.0004
744 PERICARDITIS 7 0.0004
745 THYROID CANCER 5 0.0004
746 FACE OEDEMA 7 0.0004
747 NEURALGIA 10 0.0004
748 OEDEMA 22 0.0004
749 HYPOTENSION 81 0.0004
750 METASTASES TO LIVER 7 0.0004
751 APHASIA 12 0.0004
752 EMPHYSEMA 4 0.0004
753 HYPERHIDROSIS 51 0.0004
754 CARDIOVASCULAR DISORDER 10 0.0004
755 EYELID PTOSIS 4 0.0004
756 DYSPNOEA 222 0.0004
757 SHOCK 9 0.0004
758 URINARY RETENTION 13 0.0004
759 INFUSION SITE PAIN 5 0.0004
760 ANOREXIA 5 0.0004
761 HYPOAESTHESIA 57 0.0004
762 GASTRITIS 10 0.0004
763 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 27 0.0004
764 FULL BLOOD COUNT ABNORMAL 4 0.0004
765 EYE HAEMORRHAGE 5 0.0004
766 DEVICE MALFUNCTION 26 0.0004
767 IMPAIRED HEALING 12 0.0004
768 ECZEMA 19 0.0004
769 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
770 HYPERGLYCAEMIA 13 0.0004
771 HEPATITIS 9 0.0004
772 MYOCARDITIS 4 0.0003
773 RESPIRATORY TRACT INFECTION 9 0.0003
774 DRUG INEFFECTIVE 453 0.0003
775 RENAL DISORDER 16 0.0003
776 NAUSEA 270 0.0003
777 OSTEOPOROSIS 14 0.0003
778 COVID-19 PNEUMONIA 4 0.0003
779 DECREASED APPETITE 78 0.0003
780 MYALGIA 57 0.0003
781 HAEMORRHAGE INTRACRANIAL 5 0.0003
782 BACK PAIN 77 0.0003
783 HEPATITIS C 4 0.0003
784 LIVER FUNCTION TEST INCREASED 7 0.0003
785 DYSPHONIA 19 0.0003
786 HYPERCALCAEMIA 4 0.0003
787 HAEMOPTYSIS 9 0.0003
788 HAEMOGLOBIN DECREASED 33 0.0003
789 ALOPECIA 63 0.0003
790 OXYGEN SATURATION DECREASED 18 0.0003
791 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
792 CONDITION AGGRAVATED 97 0.0003
793 ATRIAL FIBRILLATION 31 0.0003
794 ULCER 5 0.0003
795 PRODUCT USE ISSUE 59 0.0003
796 ABSCESS 5 0.0003
797 METABOLIC ACIDOSIS 10 0.0003
798 ORAL PAIN 7 0.0003
799 POST PROCEDURAL COMPLICATION 6 0.0003
800 CHEST PAIN 57 0.0003
801 NODULE 4 0.0003
802 METASTASES TO BONE 5 0.0003
803 DRUG LEVEL INCREASED 5 0.0003
804 CONVULSION 17 0.0003
805 ABDOMINAL PAIN 69 0.0003
806 LUNG NEOPLASM MALIGNANT 12 0.0003
807 SYNCOPE 29 0.0003
808 MENTAL STATUS CHANGES 8 0.0003
809 CARDIO-RESPIRATORY ARREST 12 0.0003
810 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
811 DERMATITIS 6 0.0003
812 MUSCULOSKELETAL PAIN 15 0.0003
813 BLOOD PRESSURE DECREASED 19 0.0003
814 GASTROENTERITIS 4 0.0003
815 COMA 13 0.0003
816 DYSURIA 10 0.0003
817 OEDEMA PERIPHERAL 33 0.0003
818 DEHYDRATION 36 0.0003
819 RENAL INJURY 8 0.0003
820 PULMONARY MASS 4 0.0003
821 HEPATIC FUNCTION ABNORMAL 10 0.0003
822 RASH PAPULAR 6 0.0003
823 BLISTER 15 0.0003
824 BRADYCARDIA 14 0.0003
825 URINARY TRACT INFECTION 45 0.0003
826 EPILEPSY 8 0.0003
827 THROAT TIGHTNESS 7 0.0003
828 CELLULITIS 13 0.0003
829 CONSTIPATION 56 0.0003
830 INFUSION RELATED REACTION 17 0.0003
831 ORAL HERPES 5 0.0003
832 HYPOACUSIS 11 0.0003
833 MYOCARDIAL INFARCTION 44 0.0003
834 HAEMATOCRIT DECREASED 5 0.0003
835 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
836 PREGNANCY 5 0.0002
837 PRESYNCOPE 6 0.0002
838 ERYTHEMA 50 0.0002
839 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
840 PNEUMONIA ASPIRATION 6 0.0002
841 BLOOD UREA INCREASED 4 0.0002
842 LABORATORY TEST ABNORMAL 7 0.0002
843 CARDIAC FAILURE CONGESTIVE 19 0.0002
844 COGNITIVE DISORDER 11 0.0002
845 TREMOR 39 0.0002
846 GASTROINTESTINAL DISORDER 21 0.0002
847 ERECTILE DYSFUNCTION 6 0.0002
848 HYPERTENSION 49 0.0002
849 THERAPEUTIC RESPONSE DECREASED 14 0.0002
850 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
851 PRODUCT PRESCRIBING ISSUE 5 0.0002
852 FEELING HOT 14 0.0002
853 COLD SWEAT 4 0.0002
854 HYPERSENSITIVITY 42 0.0002
855 RASH MACULO-PAPULAR 5 0.0002
856 CHEST DISCOMFORT 23 0.0002
857 PARAESTHESIA 35 0.0002
858 CYSTITIS 7 0.0002
859 BONE DISORDER 4 0.0002
860 FATIGUE 169 0.0002
861 LACTIC ACIDOSIS 7 0.0002
862 GASTRIC ULCER 4 0.0002
863 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
864 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
865 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
866 HAEMATURIA 7 0.0002
867 PAIN IN EXTREMITY 60 0.0002
868 PSYCHOTIC DISORDER 6 0.0002
869 HAEMORRHAGE 21 0.0002
870 BLOOD POTASSIUM DECREASED 6 0.0002
871 CYTOKINE RELEASE SYNDROME 4 0.0002
872 HYPOPHAGIA 5 0.0002
873 ARTHRALGIA 81 0.0002
874 OROPHARYNGEAL PAIN 18 0.0002
875 ANAPHYLACTIC SHOCK 5 0.0002
876 CARDIAC DISORDER 18 0.0002
877 SOMNOLENCE 38 0.0002
878 PRODUCTIVE COUGH 9 0.0002
879 DEATH 162 0.0002
880 MENTAL DISORDER 8 0.0002
881 PALLOR 5 0.0002
882 FALL 61 0.0002
883 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
884 BREAST CANCER 17 0.0002
885 HEADACHE 114 0.0002
886 DIARRHOEA 117 0.0002
887 PALPITATIONS 21 0.0002
888 ASTHENIA 67 0.0002
889 ARTHRITIS 14 0.0002
890 CHROMATURIA 4 0.0002
891 CEREBROVASCULAR ACCIDENT 30 0.0002
892 COVID-19 31 0.0002
893 ADVERSE EVENT 16 0.0002
894 SEIZURE 20 0.0002
895 PANCREATITIS 9 0.0002
896 RASH ERYTHEMATOUS 8 0.0002
897 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
898 FIBROMYALGIA 4 0.0002
899 DRUG ADMINISTRATION ERROR 5 0.0002
900 MEDICATION ERROR 9 0.0002
901 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
902 DRY EYE 8 0.0002
903 ABDOMINAL PAIN LOWER 4 0.0002
904 WEIGHT DECREASED 44 0.0002
905 DIABETES MELLITUS 12 0.0002
906 EMOTIONAL DISTRESS 19 0.0002
907 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
908 CONFUSIONAL STATE 25 0.0002
909 RASH GENERALISED 4 0.0002
910 PLASMA CELL MYELOMA 6 0.0002
911 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
912 ABDOMINAL DISTENSION 16 0.0002
913 SKIN DISCOLOURATION 7 0.0002
914 VISUAL ACUITY REDUCED 5 0.0002
915 MUSCULAR WEAKNESS 17 0.0001
916 DIZZINESS 74 0.0001
917 MALAISE 64 0.0001
918 HYPOGLYCAEMIA 7 0.0001
919 SWELLING FACE 9 0.0001
920 EPISTAXIS 10 0.0001
921 HEPATIC ENZYME INCREASED 9 0.0001
922 HEART RATE INCREASED 13 0.0001
923 RASH PRURITIC 7 0.0001
924 PAIN 79 0.0001
925 TREATMENT NONCOMPLIANCE 7 0.0001
926 FLUSHING 13 0.0001
927 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
928 ABNORMAL BEHAVIOUR 5 0.0001
929 DISORIENTATION 5 0.0001
930 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
931 AGITATION 9 0.0001
932 LETHARGY 7 0.0001
933 ROAD TRAFFIC ACCIDENT 5 0.0001
934 FLUID RETENTION 6 0.0001
935 INFLUENZA 13 0.0001
936 ABDOMINAL PAIN UPPER 24 0.0001
937 HYPERKALAEMIA 4 0.0001
938 HEART RATE DECREASED 4 0.0001
939 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
940 ACCIDENTAL OVERDOSE 4 0.0001
941 BRONCHITIS 8 0.0001
942 URTICARIA 17 0.0001
943 WHEEZING 6 0.0001
944 DISTURBANCE IN ATTENTION 5 0.0001
945 RASH 40 0.0001
946 ANGIOEDEMA 4 0.0001
947 VISION BLURRED 12 0.0001
948 BURNING SENSATION 6 0.0001
949 OCULAR HYPERAEMIA 4 0.0001
950 GAIT DISTURBANCE 16 0.0001
951 DISCOMFORT 5 0.0001
952 UNEVALUABLE EVENT 6 0.0001
953 RHINORRHOEA 5 0.0001
954 PRURITUS 29 0.0001
955 MIGRAINE 7 0.0001
956 INFLUENZA LIKE ILLNESS 6 0.0001
957 MEMORY IMPAIRMENT 10 0.0001
958 CONTUSION 7 0.0001
959 HAEMATOCHEZIA 4 0.0001
960 NECK PAIN 4 0.0001
961 ADVERSE DRUG REACTION 6 0.0001
962 SWELLING 6 0.0001
963 AMNESIA 4 0.0001
964 DYSPEPSIA 6 0.0001
965 MUSCLE SPASMS 11 0.0001
966 PERIPHERAL SWELLING 9 0.0001
967 WEIGHT INCREASED 13 0.0001
968 MOBILITY DECREASED 4 0.0001
969 FEELING ABNORMAL 13 0.0001
970 NASOPHARYNGITIS 10 0.0001
971 DYSGEUSIA 4 0.0001
972 CHRONIC KIDNEY DISEASE 4 0.0001
973 PRODUCT QUALITY ISSUE 7 0.0001
974 NO ADVERSE EVENT 9 0.0000
975 ANXIETY 14 0.0000
976 VISUAL IMPAIRMENT 6 0.0000
977 ABDOMINAL DISCOMFORT 8 0.0000
978 BLOOD PRESSURE INCREASED 7 0.0000
979 OVERDOSE 9 0.0000
980 INSOMNIA 10 0.0000
981 BLOOD GLUCOSE INCREASED 7 0.0000
982 ASTHMA 4 0.0000
983 DEPRESSION 7 0.0000
984 HOSPITALISATION 4 0.0000